John Sieckhaus - 30 Nov 2023 Form 4/A - Amendment Insider Report for BioSig Technologies, Inc. (BSGM)

Reporting relationship: Chief Operating Officer
Issuer ticker: BSGM
Reported as of: 30 Nov 2023
Net transaction value: $0
SEC form: 4/A - Amendment
Accepted by SEC: 05 Dec 2023, 18:17:36 UTC
Original report date: 04 Dec 2023
Prior SEC filing: 09 May 2023
Source filing: View source filing
Reporting owner signature: /s/ John Sieckhaus

Key filing fact

John Sieckhaus filed Form 4/A - Amendment for BioSig Technologies, Inc. (BSGM) on 05 Dec 2023.

Key facts

This page summarizes John Sieckhaus's Form 4/A - Amendment filing for BioSig Technologies, Inc. (BSGM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 05 Dec 2023, 18:17.

Change

Previous filing in this sequence was filed on 09 May 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BSGM transaction

Common Stock

Award

Transaction value: $0
Shares: +92,300
Change %: +25%
Price: $0.000000
Shares after: 457,920
Date: 30 Nov 2023
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On December 4th, 2023, the reporting person filed a Form 4, which inadvertently reported the award as a stock option (right to buy) instead of shares of restricted stock.

Footnote F2

The shares of restricted stock fully vested on November 30, 2023, the date of the grant.